{"transactions":[{"id":4632910,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-10-02T00:04:09.000Z","date":"2026-09-29","kind":"sale","planned":false,"acquired":false,"shares":27370,"price":9.46,"value":258920.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The prices sold ranged from $9.445 to $9.48 per ordinary share. The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":52731,"source":{"system":"sec-edgar","filing":"0001796536-26-000010","document":"form4-10012026_081003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801198/000179653626000010/form4-10012026_081003.xml","form_type":"4"}},{"id":4627557,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-28T20:10:06.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":20986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units (the \"RSUs\"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":80101,"source":{"system":"sec-edgar","filing":"0001796536-26-000009","document":"form4-09282026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801198/000179653626000009/form4-09282026_040901.xml","form_type":"4"}},{"id":681554,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2026-08-19T23:00:03.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2026, the Reporting Person was issued a non-qualified stock option to purchase 6,000 shares of common stock (the \"Options\") at an exercise price of $1.36 per share (equal to the closing price on the grant date, August 17, 2026) and shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the grant date. The stock options were granted pursuant to the Issuer's non-employee director compensation policy and issued under the Issuer's 2023 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 17, 2026, the Reporting Person was issued a non-qualified stock option to purchase 6,000 shares of common stock (the \"Options\") at an exercise price of $1.36 per share (equal to the closing price on the grant date, August 17, 2026) and shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the grant date. The stock options were granted pursuant to the Issuer's non-employee director compensation policy and issued under the Issuer's 2023 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include the stock options previously granted to the Reporting Person."}],"balance_after":6000,"derivative":{"exercise_price":1.36,"expiration_date":"2036-08-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001493152-26-039285","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855485/000149315226039285/ownership.xml","form_type":"4"}},{"id":737490,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-15T22:50:54.000Z","date":"2026-06-15","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":25.05,"value":50100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":21095,"source":{"system":"sec-edgar","filing":"0001796536-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000179653626000007/ownership.xml","form_type":"4"}},{"id":761230,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-05-27T21:26:06.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":212,"price":309.5896,"value":65632.9952,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award\npreviously granted to the Reporting Person. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general\nmeeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested\nsecurities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001796536-26-000005","document":"wk-form4_1779917164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000179653626000005/wk-form4_1779917164.xml","form_type":"4"}},{"id":774430,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T22:38:30.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":14058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027."}],"balance_after":14058,"derivative":{"exercise_price":25.8,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":14058},"source":{"system":"sec-edgar","filing":"0001796536-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000179653626000004/ownership.xml","form_type":"4"}},{"id":774429,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T22:38:30.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":7751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027."}],"balance_after":23095,"source":{"system":"sec-edgar","filing":"0001796536-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000179653626000004/ownership.xml","form_type":"4"}},{"id":984814,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-12-01T21:57:56.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":false,"shares":34151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors (the \"Board\") or otherwise ceases to serve as a director, unless the Board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":0,"derivative":{"exercise_price":12.23,"expiration_date":"2034-06-04","underlying":"Ordinary Shares","underlying_shares":34151},"source":{"system":"sec-edgar","filing":"0001796536-25-000005","document":"wk-form4_1764626273.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000179653625000005/wk-form4_1764626273.xml","form_type":"4"}},{"id":984813,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2025-12-01T21:57:56.000Z","date":"2025-11-26","kind":"sale","planned":false,"acquired":false,"shares":804,"price":342.474,"value":275349.096,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.42 to $342.675, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001796536-25-000005","document":"wk-form4_1764626273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000179653625000005/wk-form4_1764626273.xml","form_type":"4"}},{"id":984812,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2025-12-01T21:57:56.000Z","date":"2025-11-26","kind":"sale","planned":false,"acquired":false,"shares":1823,"price":340.2004,"value":620185.3292,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.04 to $340.68, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":804,"source":{"system":"sec-edgar","filing":"0001796536-25-000005","document":"wk-form4_1764626273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000179653625000005/wk-form4_1764626273.xml","form_type":"4"}},{"id":984811,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2025-12-01T21:57:56.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":true,"shares":2627,"price":159.03,"value":417771.81,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":2627,"source":{"system":"sec-edgar","filing":"0001796536-25-000005","document":"wk-form4_1764626273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000179653625000005/wk-form4_1764626273.xml","form_type":"4"}},{"id":1044576,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-09-09T21:31:54.000Z","date":"2025-09-05","kind":"exercise","planned":false,"acquired":false,"shares":34645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefore are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors (the \"Board\") or otherwise ceases to serve as a director, unless the Board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":0,"derivative":{"exercise_price":11.98,"expiration_date":"2032-06-21","underlying":"Ordinary Shares","underlying_shares":34645},"source":{"system":"sec-edgar","filing":"0001651308-25-000139","document":"wk-form4_1757453510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000139/wk-form4_1757453510.xml","form_type":"4"}},{"id":1044575,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2025-09-09T21:31:54.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":2665,"price":337,"value":898105.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-25-000139","document":"wk-form4_1757453510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000139/wk-form4_1757453510.xml","form_type":"4"}},{"id":1044574,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2025-09-09T21:31:54.000Z","date":"2025-09-05","kind":"exercise","planned":false,"acquired":true,"shares":2665,"price":155.68,"value":414887.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":2665,"source":{"system":"sec-edgar","filing":"0001651308-25-000139","document":"wk-form4_1757453510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000139/wk-form4_1757453510.xml","form_type":"4"}},{"id":1103513,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T17:50:13.000Z","date":"2025-06-20","kind":"sale","planned":true,"acquired":false,"shares":2405,"price":37.39,"value":89922.95,"ownership":{"direct":true},"balance_after":15344,"source":{"system":"sec-edgar","filing":"0000950170-25-088878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025088878/ownership.xml","form_type":"4"}},{"id":1136675,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-22T23:42:58.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":22750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":22750,"derivative":{"exercise_price":18.19,"expiration_date":"2035-05-20","underlying":"Ordinary Shares","underlying_shares":22750},"source":{"system":"sec-edgar","filing":"0001651308-25-000086","document":"wk-form4_1747957367.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000086/wk-form4_1747957367.xml","form_type":"4"}},{"id":1136674,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-22T23:42:58.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":10985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":57226,"source":{"system":"sec-edgar","filing":"0001651308-25-000086","document":"wk-form4_1747957367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130825000086/wk-form4_1747957367.xml","form_type":"4"}},{"id":1142065,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-19T22:33:25.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":10787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026."}],"balance_after":10787,"derivative":{"exercise_price":34.84,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":10787},"source":{"system":"sec-edgar","filing":"0000950170-25-074666","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025074666/ownership.xml","form_type":"4"}},{"id":1142064,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T22:33:25.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":5740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026."}],"balance_after":17749,"source":{"system":"sec-edgar","filing":"0000950170-25-074666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017025074666/ownership.xml","form_type":"4"}},{"id":1397820,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-30T17:35:45.000Z","date":"2024-09-27","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of September 27, 2024."}],"balance_after":1000,"derivative":{"exercise_price":1.41,"expiration_date":"2034-09-27","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-24-110454","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000095017024110454/ownership.xml","form_type":"4"}},{"id":1459433,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-03T18:07:33.000Z","date":"2024-07-02","kind":"sale","planned":true,"acquired":false,"shares":584,"price":40.98,"value":23932.32,"ownership":{"direct":true},"balance_after":12009,"source":{"system":"sec-edgar","filing":"0000950170-24-081302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024081302/ownership.xml","form_type":"4"}},{"id":1472850,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T18:22:55.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025."}],"balance_after":9900,"derivative":{"exercise_price":37.42,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":9900},"source":{"system":"sec-edgar","filing":"0000950170-24-075485","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024075485/ownership.xml","form_type":"4"}},{"id":1472849,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T18:22:55.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":5345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 18, 2025."}],"balance_after":12593,"source":{"system":"sec-edgar","filing":"0000950170-24-075485","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024075485/ownership.xml","form_type":"4"}},{"id":1484546,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T23:58:22.000Z","date":"2024-06-10","kind":"sale","planned":true,"acquired":false,"shares":1737,"price":41.1,"value":71390.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":7248,"source":{"system":"sec-edgar","filing":"0000950170-24-071548","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000095017024071548/ownership.xml","form_type":"4"}},{"id":1486084,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-06-07T20:55:28.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":34151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":34151,"derivative":{"exercise_price":12.23,"expiration_date":"2034-06-04","underlying":"Ordinary Shares","underlying_shares":34151},"source":{"system":"sec-edgar","filing":"0001651308-24-000057","document":"wk-form4_1717793720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000057/wk-form4_1717793720.xml","form_type":"4"}},{"id":1486083,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-07T20:55:28.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":16341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":46241,"source":{"system":"sec-edgar","filing":"0001651308-24-000057","document":"wk-form4_1717793720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130824000057/wk-form4_1717793720.xml","form_type":"4"}},{"id":1753087,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-31T18:46:23.000Z","date":"2023-10-27","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on August 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of October 27, 2023."}],"balance_after":1000,"derivative":{"exercise_price":6.06,"expiration_date":"2033-10-27","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001171843-23-006569","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000117184323006569/ownership.xml","form_type":"4"}},{"id":1840865,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-30T18:34:29.000Z","date":"2023-06-30","kind":"sale","planned":false,"acquired":false,"shares":585,"price":46.76,"value":27354.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023."}],"balance_after":8985,"source":{"system":"sec-edgar","filing":"0001209191-23-040269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123040269/doc4.xml","form_type":"4"}},{"id":1843234,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2023-06-27T21:21:22.000Z","date":"2023-06-23","kind":"sale","planned":true,"acquired":false,"shares":478,"price":182.6515,"value":87307.417,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.34 to $183.05, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-23-000101","document":"wf-form4_168790086732122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130823000101/wf-form4_168790086732122.xml","form_type":"4"}},{"id":1843233,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2023-06-27T21:21:22.000Z","date":"2023-06-23","kind":"sale","planned":true,"acquired":false,"shares":100,"price":180.74,"value":18074.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023."}],"balance_after":478,"source":{"system":"sec-edgar","filing":"0001651308-23-000101","document":"wf-form4_168790086732122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130823000101/wf-form4_168790086732122.xml","form_type":"4"}},{"id":1848707,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2023-06-20T23:08:04.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":26975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":26975,"derivative":{"exercise_price":16.41,"expiration_date":"2033-06-14","underlying":"Ordinary Shares","underlying_shares":26975},"source":{"system":"sec-edgar","filing":"0001651308-23-000099","document":"wf-form4_168730246724090.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130823000099/wf-form4_168730246724090.xml","form_type":"4"}},{"id":1848706,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-20T23:08:04.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":12922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":37414,"source":{"system":"sec-edgar","filing":"0001651308-23-000099","document":"wf-form4_168730246724090.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130823000099/wf-form4_168730246724090.xml","form_type":"4"}},{"id":1860137,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T18:31:34.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":7110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024."}],"balance_after":7110,"derivative":{"exercise_price":51.82,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":7110},"source":{"system":"sec-edgar","filing":"0001209191-23-035690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123035690/doc4.xml","form_type":"4"}},{"id":1860136,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T18:31:34.000Z","date":"2023-06-08","kind":"sale","planned":false,"acquired":false,"shares":1485,"price":51.65,"value":76700.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023."}],"balance_after":9570,"source":{"system":"sec-edgar","filing":"0001209191-23-035690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123035690/doc4.xml","form_type":"4"}},{"id":1860135,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T18:31:34.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":3860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024."}],"balance_after":11055,"source":{"system":"sec-edgar","filing":"0001209191-23-035690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919123035690/doc4.xml","form_type":"4"}},{"id":2219239,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T19:48:19.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":6245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023."}],"balance_after":6245,"derivative":{"exercise_price":60.57,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":6245},"source":{"system":"sec-edgar","filing":"0001209191-22-039770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122039770/doc4.xml","form_type":"4"}},{"id":2219238,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-29T19:48:19.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023."}],"balance_after":7195,"source":{"system":"sec-edgar","filing":"0001209191-22-039770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919122039770/doc4.xml","form_type":"4"}},{"id":2221751,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2022-06-24T21:37:38.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":34645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":34645,"derivative":{"exercise_price":11.98,"expiration_date":"2032-06-21","underlying":"Ordinary Shares","underlying_shares":34645},"source":{"system":"sec-edgar","filing":"0001651308-22-000105","document":"wf-form4_165610664484850.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130822000105/wf-form4_165610664484850.xml","form_type":"4"}},{"id":2221750,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-24T21:37:38.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":16692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share unites were granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":24492,"source":{"system":"sec-edgar","filing":"0001651308-22-000105","document":"wf-form4_165610664484850.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130822000105/wf-form4_165610664484850.xml","form_type":"4"}},{"id":2241614,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T16:15:13.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on June 3, 2023."}],"balance_after":15000,"derivative":{"exercise_price":0.9728,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-22-021187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924322021187/doc4.xml","form_type":"4"}},{"id":2649496,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-30T23:58:18.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":7255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest with respect to 1/36th of the shares monthly such that the option shall fully vest on the third anniversary of the grant date."}],"balance_after":7255,"derivative":{"exercise_price":96.29,"expiration_date":"2031-06-29","underlying":"Common Stock","underlying_shares":7255},"source":{"system":"sec-edgar","filing":"0001209191-21-044165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121044165/doc4.xml","form_type":"4"}},{"id":2649495,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T23:58:18.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":3895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/3rd of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the third anniversary of the grant date."}],"balance_after":3895,"source":{"system":"sec-edgar","filing":"0001209191-21-044165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121044165/doc4.xml","form_type":"4"}},{"id":2659926,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2021-06-21T20:35:42.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":17498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":17498,"derivative":{"exercise_price":26.53,"expiration_date":"2031-06-15","underlying":"Ordinary Shares","underlying_shares":17498},"source":{"system":"sec-edgar","filing":"0001651308-21-000120","document":"wf-form4_162430771425098.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000120/wf-form4_162430771425098.xml","form_type":"4"}},{"id":2659925,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-21T20:35:42.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":7800,"source":{"system":"sec-edgar","filing":"0001651308-21-000120","document":"wf-form4_162430771425098.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130821000120/wf-form4_162430771425098.xml","form_type":"4"}},{"id":2680684,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T16:30:37.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on June 3, 2022."}],"balance_after":15000,"derivative":{"exercise_price":8.98,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-21-022044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924321022044/doc4.xml","form_type":"4"}},{"id":3046038,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2020-08-26T20:51:44.000Z","date":"2020-08-24","kind":"grant","acquired":true,"shares":27482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":27482,"derivative":{"exercise_price":18.26,"expiration_date":"2030-08-23","underlying":"Ordinary Shares","underlying_shares":27482},"source":{"system":"sec-edgar","filing":"0001651308-20-000141","document":"wf-form4_159847508819916.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130820000141/wf-form4_159847508819916.xml","form_type":"4"}},{"id":3128876,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-01T17:05:59.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on May 28, 2021"}],"balance_after":15000,"derivative":{"exercise_price":15.43,"expiration_date":"2030-05-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-20-014734","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924320014734/doc4.xml","form_type":"4"}},{"id":3333801,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-20T08:05:24.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the total number of shares subject to the option shall vest on December 19, 2020 and the remaining 50% shall vest on December 19, 2021, subject to the reporting person's continuous service with Molecular Templates, Inc."}],"balance_after":25000,"derivative":{"exercise_price":12.69,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-19-029722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924319029722/doc4.xml","form_type":"4"}}]}